Nrgene Technologies Valuation

NRGN Stock  ILA 625.10  48.40  8.39%   
At this time, the firm appears to be overvalued. Nrgene Technologies secures a last-minute Real Value of 593.85 per share. The latest price of the firm is 625.1. Our model forecasts the value of Nrgene Technologies from analyzing the firm fundamentals such as Profit Margin of (2.00) %, return on equity of -0.44, and Current Valuation of 28.77 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
625.10
Please note that Nrgene Technologies' price fluctuation is very steady at this time. Calculation of the real value of Nrgene Technologies is based on 3 months time horizon. Increasing Nrgene Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Nrgene Technologies is useful when determining the fair value of the Nrgene stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Nrgene Technologies. Since Nrgene Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nrgene Stock. However, Nrgene Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  625.1 Real  593.85 Hype  625.1 Naive  600.88
The real value of Nrgene Stock, also known as its intrinsic value, is the underlying worth of Nrgene Technologies Company, which is reflected in its stock price. It is based on Nrgene Technologies' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Nrgene Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nrgene Technologies' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
587.13
Downside
593.85
Real Value
687.61
Upside
Estimating the potential upside or downside of Nrgene Technologies helps investors to forecast how Nrgene stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nrgene Technologies more accurately as focusing exclusively on Nrgene Technologies' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
371.12521.77672.41
Details
Hype
Prediction
LowEstimatedHigh
618.38625.10631.82
Details
Naive
Forecast
LowNext ValueHigh
594.16600.88607.60
Details

Nrgene Technologies Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Nrgene Technologies's current stock value. Our valuation model uses many indicators to compare Nrgene Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nrgene Technologies competition to find correlations between indicators driving Nrgene Technologies's intrinsic value. More Info.
Nrgene Technologies is regarded second in price to book category among related companies. It is regarded second in price to sales category among related companies fabricating about  12.88  of Price To Sales per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Nrgene Technologies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nrgene Technologies' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nrgene Technologies' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nrgene Technologies' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nrgene Technologies and how it compares across the competition.

About Nrgene Technologies Valuation

The stock valuation mechanism determines the current worth of Nrgene Technologies on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Nrgene Technologies. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nrgene Technologies based exclusively on its fundamental and basic technical indicators. By analyzing Nrgene Technologies's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Nrgene Technologies's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nrgene Technologies. We calculate exposure to Nrgene Technologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nrgene Technologies's related companies.
Energin .R Technologies 2009 LTD., a genomic big data company, provides computational tools to seed and food companies worldwide. The company was founded in 2009 and is headquartered in Ness Ziona, Israel. ENERGIN R operates under SoftwareApplication classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 48 people.

8 Steps to conduct Nrgene Technologies' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nrgene Technologies' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nrgene Technologies' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Nrgene Technologies' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Nrgene Technologies' revenue streams: Identify Nrgene Technologies' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Nrgene Technologies' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Nrgene Technologies' growth potential: Evaluate Nrgene Technologies' management, business model, and growth potential.
  • Determine Nrgene Technologies' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nrgene Technologies' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nrgene Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Nrgene Stock analysis

When running Nrgene Technologies' price analysis, check to measure Nrgene Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nrgene Technologies is operating at the current time. Most of Nrgene Technologies' value examination focuses on studying past and present price action to predict the probability of Nrgene Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nrgene Technologies' price. Additionally, you may evaluate how the addition of Nrgene Technologies to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Please note, there is a significant difference between Nrgene Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nrgene Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nrgene Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.